Axon Enterprise, Inc. Website

Axon Enterprise, Inc.

NasdaqGS-AXON

Basic

  • Market Cap

    $23.67B

  • EV

    $23.07B

  • Shares Out

    75.46M

  • Revenue

    $1,563.39M

  • Employees

    3,330

Margins

  • Gross

    61.11%

  • EBITDA

    12.14%

  • Operating

    10.05%

  • Pre-Tax

    9.91%

  • Net

    11.14%

  • FCF

    8.29%

Returns (5Yr Avg)

  • ROA

    1.48%

  • ROTA

    3.01%

  • ROE

    2.96%

  • ROCE

    -1.09%

  • ROIC

    1.12%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $328.38

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,320.54M

  • Net Debt

    -$600.09M

  • Debt/Equity

    0.45

  • EBIT/Interest

    22.46

Growth (CAGR)

  • Rev 3Yr

    31.92%

  • Rev 5Yr

    30.06%

  • Rev 10Yr

    27.49%

  • Dil EPS 3Yr

    325.43%

  • Dil EPS 5Yr

    35.81%

  • Dil EPS 10Yr

    21.12%

  • Rev Fwd 2Yr

    22.39%

  • EBITDA Fwd 2Yr

    33.01%

  • EPS Fwd 2Yr

    17.43%

  • EPS LT Growth Est

    15.1%

Dividends

  • Yield

  • Payout

  • DPS

  • DPS Growth 3Yr

  • DPS Growth 5Yr

  • DPS Growth 10Yr

  • DPS Growth Fwd 2Yr

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

530.9

681

863.4

1,189.9

1,563.4

Total Revenues % Chg.

26.4%

28.3%

26.8%

37.8%

31.4%

Cost of Goods Sold, Total

223.6

264.7

322.5

461.3

608

Gross Profit

307.3

416.3

540.9

728.6

955.4

Selling General & Admin Expenses, Total

211

309.1

518.7

405.9

488.9

R&D Expenses

100.7

120.2

190.4

229.5

300.4

Other Operating Expenses

9

Other Operating Expenses, Total

311.7

429.3

709

635.4

798.3

Operating Income

-4.4

-13

-168.1

93.3

157.1

Interest Expense, Total

-0.5

-7

Interest And Investment Income

8.5

1.5

4.8

49.1

Net Interest Expenses

8.5

1.5

4.3

42.1

Currency Exchange Gains (Loss)

-0.9

-0.5

Other Non Operating Income (Expenses)

7.9

25.3

0.9

0.4

EBT, Excl. Unusual Items

4.1

-5.1

-141.4

97.5

199.1

Merger & Related Restructuring Charges

-2.3

Gain (Loss) On Sale Of Investments

99

-41.8

Asset Writedown

-2

-1.2

Legal Settlements

EBT, Incl. Unusual Items

2.1

-6.3

-141.4

196.5

155

Income Tax Expense

1.2

-4.6

-81.4

49.4

-19.2

Earnings From Continuing Operations

0.9

-1.7

-60

147.1

174.2

Net Income

0.9

-1.7

-60

147.1

174.2

Net Income to Common Incl Extra Items

0.9

-1.7

-60

147.1

174.2

Net Income to Common Excl. Extra Items

0.9

-1.7

-60

147.1

174.2

Total Shares Outstanding

59.5

63.8

70.9

71.5

75.3

Weighted Avg. Shares Outstanding

59.2

61.8

66.2

71.1

74.2

Weighted Avg. Shares Outstanding Dil

60

61.8

66.2

72.5

75.5

EPS

0

-0

-0.9

2.1

2.3

EPS Diluted

0

-0

-0.9

2

2.3

EBITDA

7

-0.5

-149.4

117.6

189.7

Effective Tax Rate

57.4%

72.6%

57.5%

25.1%

-12.4%